Using a new bioengineering process they developed and call “self-condensation,” researchers in the US and Japan are moving medical science closer to one day growing human organ tissues from tissue-engineered cells for regenerative medicine. The scientists tissue-engineered human pancreatic islets that develop a circulatory system, secrete hormones like insulin, and successfully treat sudden-onset type 1 diabetes in transplanted mice.
Annually, there are 79,000 new diagnoses of type 1 diabetes – a chronic, life-threatening disease. If this stem cell-based tissue-engineering process can overcome the challenge of ensuring a blood supply to nourish the transplant tissues, it may serve as a curative strategy that could help millions of children and adults around the world.
Click here to read the full article published on Genetic Engineering & Biotechnology News. Or read the paper published May 8, 2018 by the team entitled “Self-Condensation Culture Enable Vascularization of Tissue Fragments for Efficient Therapeutic Transplantation.”